NASDAQ:DRDB · NASDAQ Global Select
-$0.01 today
Vol 0.19M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Roman DBDR Acquisition Corp. II earnings power becomes long-term shareholder value. Use this page to compare DRDB returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
3.2%
avg 1.7%
ROIC
-0.9%
avg -0.5%
ROA
3.2%
avg 1.7%
Analysis
ROE is currently the strongest return metric at 3.2% versus its period average of 1.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Al Basseri | Chief Technology Officer | — | — | — | — | — |
Donald G. Basile | Chief Technology Officer | — | — | 60 | — | — |
Dixon R. Doll Jr. | Chief Executive Officer & Chairman of the Board | — | — | 58 | — | — |
John J. Birmingham | Chief Financial Officer and Principal Accounting & Financial Officer | — | — | 52 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$359.09M
Andretti Acquisition Corp. II
NASDAQ:POLE
$318.41M
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
$272.20M
Plum Acquisition Corp. IV
NASDAQ:PLMK
$258.67M
FACT II Acquisition Corp
NASDAQ:FACT
$258.54M
Rithm Acquisition Corp.
NYSE:RAC
$248.67M
Sizzle Acquisition Corp. II
NASDAQ:SZZL
$244.97M
Highview Merger Corp.
NASDAQ:HVMCU
$243.93M
Newbury Street II Acquisition Corp
NASDAQ:NTWO
$193.30M
Range Capital Acquisition Corp.
NASDAQ:RANG
$171.52M
Who manages DRDB?
Roman DBDR Acquisition Corp. II (DRDB) lists 4 active executives. The top listed executive is Al Basseri, Chief Technology Officer.
Are DRDB insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.